Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5005/jp-journals-10071-23491 http://scihub22266oqcxt.onion/10.5005/jp-journals-10071-23491 32963442!7482359!32963442     free     free     free       Indian+J+Crit+Care+Med 2020 ; 24 (7): 570-574 Nephropedia Template TP {{tp|p=32963442|t=2020. Past, Present, and Future of Remdesivir: An Overview of the Antiviral in Recent Times |pdf=|usr=}}{{32963442}} gab.com Text Past, Present, and Future of Remdesivir: An Overview of the Antiviral in Recent Times JO: Indian J Crit Care Med http://www.kidney.de/pget.php?&tw=1&pmid=32963442 #FOAvip In the current COVID-19 pandemic, evidence to justify the use of any specific antiviral drug with proven efficacy is not yet available. Antiviral drug development always remains a challenge to the scientists. Remdesivir has emerged as a promising molecule, based on results of clinical trials and observational studies and has receieved marketing approval for COVID-19 treatment under "emergency use authorization" in countries such as United States. Remdesivir is a newer antiviral drug that acts as an RNA-dependent RNA polymerase (RdRp) inhibitor targeting the viral genome replication process. Therapeutic efficacy was first demonstrated by suppressing viral replication in Ebola-infected rhesus monkeys. It is available for parenteral use with reasonable safety and tolerability profile. Multiple clinical trials are going on in many countries to evaluate its safety, efficacy and tolerability. Positive outcome will make the drug capable of meeting the demand generated by both the current pandemic and future outbreak. HOW TO CITE THIS ARTICLE: Choudhury S, Chakraborty DS, Lahiry S, Chatterjee S. Past, Present, and Future of Remdesivir: An Overview of the Antiviral in Recent Times. Indian J Crit Care Med 2020;24(7):570-574. Twit Text FOAVip Past, Present, and Future of Remdesivir: An Overview of the Antiviral in Recent Times ????Indian J Crit Care Med http://www.kidney.de/pget.php?&tw=1&pmid=32963442 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32963442 #FOAvip English Wikipedia <ref>{{Cite pmid|32963442}}</ref> Past, Present, and Future of Remdesivir: An Overview of the Antiviral in Recent Times #MMPMID32963442 Choudhury S; Chakraborty DS; Lahiry S; Chatterjee S Indian J Crit Care Med 2020[Jul]; 24 (7): 570-574 PMID32963442show ga In the current COVID-19 pandemic, evidence to justify the use of any specific antiviral drug with proven efficacy is not yet available. Antiviral drug development always remains a challenge to the scientists. Remdesivir has emerged as a promising molecule, based on results of clinical trials and observational studies and has receieved marketing approval for COVID-19 treatment under "emergency use authorization" in countries such as United States. Remdesivir is a newer antiviral drug that acts as an RNA-dependent RNA polymerase (RdRp) inhibitor targeting the viral genome replication process. Therapeutic efficacy was first demonstrated by suppressing viral replication in Ebola-infected rhesus monkeys. It is available for parenteral use with reasonable safety and tolerability profile. Multiple clinical trials are going on in many countries to evaluate its safety, efficacy and tolerability. Positive outcome will make the drug capable of meeting the demand generated by both the current pandemic and future outbreak. HOW TO CITE THIS ARTICLE: Choudhury S, Chakraborty DS, Lahiry S, Chatterjee S. Past, Present, and Future of Remdesivir: An Overview of the Antiviral in Recent Times. Indian J Crit Care Med 2020;24(7):570-574. ?Past, Present, and Future of Remdesivir: An Overview of the Antiviral (epmc).pdf DeepDyve Pubget Overpricing